MicroRNA encapsulated nanocells (EnGeneIC)

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameMicroRNA encapsulated nanocells (EnGeneIC)

Drug Alias NameTargomiRs - EnGeneICEGFREDVmiR-16TargomiRsTargomiRMicroRNA packaged EDVTM nanocells - EnGeneIC

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNABiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionImmunostimulantsEpidermal growth factor receptor erbB1 modulators

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungMesothelioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesEngeneic Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEngeneic Ltd

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell LungMesothelioma

Other Information

ATC CodeN/A